Concepedia

David Lonergan

DL

Statistics

Publications

5

Citations

226

H-Index

5

Active since

1996

Affiliations

University of New Brunswick(Current)

David Lonergan is an author at University of New Brunswick specializing in pharmacy, drug discovery, and medicinal chemistry.

Publications per year

1996–2017

5

Publications

5

Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX

John H. Hutchinson, Martin W. Rowbottom, David Lonergan et al. · ACS Medicinal Chemistry Letters · 2017 · 86 citations · Full text

, , +12

Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2)

Martin W. Rowbottom, Gretchen Bain, Imelda Calderon et al. · Journal of Medicinal Chemistry · 2017 · 69 citations · Full text

, , +15

Tricyclic scaffolds for the rapid assembly of abiotic receptors

David Lonergan, Ghislain Deslongchamps · Tetrahedron · 1998 · 33 citations

, , +12

A convergent hydroxyimide module for molecular recognition

David Lonergan, Juan Riego, Ghislain Deslongchamps · Tetrahedron Letters · 1996 · 25 citations

, , +12

Comparative probe for stacking interactions in simple A:T base pair mimics

David Lonergan, Jonathan Halse, Ghislain Deslongchamps · Tetrahedron Letters · 1998 · 13 citations

, , +13

1–5 of 5